您好,欢迎光临有路网!
生物化学(第二版)影印本
QQ咨询:
有路璐璐:

生物化学(第二版)影印本

  • 作者:B.D.Hames
  • 出版社:科学出版社
  • ISBN:9787030109613
  • 出版日期:2005年07月01日
  • 页数:422
  • 定价:¥45.00
  • 猜你也喜欢

    分享领佣金
    手机购买
    城市
    店铺名称
    店主联系方式
    店铺售价
    库存
    店铺得分/总交易量
    发布时间
    操作

    新书比价

    网站名称
    书名
    售价
    优惠
    操作

    图书详情

    内容提要
    “精要速览系列(Instant Notes Series)”丛书是国外教材“Best Seller”榜的上榜教材。该系列结构新颖,视角独特;**明确,脉络分明;图表简明清晰;英文自然易懂,被国内多所**院校选用作为双语教材。先锋版是继“现代生物学精要速览”之后推出的跨学科的升级版本。
    本书是该系列中的《医药化学》分册,全书共13章,综合了化学、生物学和计算机科学的内容,扼要介绍了**设计与发现、新药开发与应用、临床试验及专利申请等。
    本书是指导大学生快速掌握医药化学基础知识的**教材,也是辅助教师授课的**教学参考书,同时可供相关专业的研究生参考。
    目录
    Abbreviations
    Preface
    About the author
    Section A-The science of medicinal chemistry
    A1 Introduction
    A2 From concept to market
    Section B-Drug targets
    B1 Enzymes
    B2 Receptors
    B3 Carrier proteins
    B4 Structural proteins
    B5 Nucleic acids
    B6 Lipids
    B7 Carbohydrates
    Section C-Pharmacokinetics
    C1 Pharmacokinetics
    C2 Drug absorption
    C3 Drug distribution
    C4 Drug metabolism
    C5 Drug excretion
    C6 Drug administration
    C7 Drug dosing
    Section D-Biological testing and bioassays
    D1 Testing drugs
    D2 Testing drugs in uitro
    D3 Testing drugs in uiuo
    Section E-Drug discovery
    E1 The lead compound
    E2 Natural sources of lead compounds
    E3 Synthetic sources of lead compounds
    Section F-Synthesis
    F1 Synthetic considerations
    F2 Stereochemistry
    F3 Combinatorial synthesis
    Section G-Structure-activity relationships
    G1 Definition of structure-activity relationshiips
    G2 Binding interactions
    G3 Functional groups as binding groups
    G4 The pharmacophore
    G5 Quantitative structure-activity relationships
    Section H-Target orientated drug design
    H1 Aims of drug design
    H2 Computer aided drug design
    H3 Simplification of complex molecules
    H4 Conformational restraint
    H5 Extra binding interactions
    H6 Enhancing existing binding interactions
    Section I-Pharmacokinetic orientated drug design
    I1 Drug solubility
    I2 Drug stability
    Section J-Patenting and manufacture
    J1 Patenting and chemical development
    J2 Optimization of reactions
    J3 Scale-up issues
    J4 Process development
    J5 Specifications
    Section K-Preclinical testing and clinical trials
    K1 Toxicology
    K2 Pharmacology and pharamceutical chemistry
    K3 Drug metabolism studies
    K4 Clinical trials
    K5 Regulatory affairs
    Section L-Case study:inhibitors of EGF-receptor kinase
    L1 Epidermal growth factor receptor
    L2 Testing procedures
    L3 From lead compound to dianilino-phthalimides
    L4 Modeling studies
    L5 4-(Phenylamino)pyrrolopyrimidines
    L6 Pyrazolopyrimidines
    Section M-History of medicinal chemistry
    M1 The age of herbs,potions and magic
    M2 The nineteenth century
    M3 A fledgling science(1900-1930)
    M4 The dawn of the antibacterial age(1930-1945)
    M5 The antibiotic age(1945-1970s)
    M6 The age of reason (1970s to present)
    Further reading
    Index

    与描述相符

    100

    北京 天津 河北 山西 内蒙古 辽宁 吉林 黑龙江 上海 江苏 浙江 安徽 福建 江西 山东 河南 湖北 湖南 广东 广西 海南 重庆 四川 贵州 云南 西藏 陕西 甘肃 青海 宁夏 新疆 台湾 香港 澳门 海外